Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Matthew French-Kim"'
Autor:
Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Aster G. Workineh, Matthew French-Kim, Alejandro Torres Chavez, Sarah Gilmore, Cliona M. Rooney, Ann M. Leen
Publikováno v:
Haematologica, Vol 108, Iss 7 (2022)
Externí odkaz:
https://doaj.org/article/6cfcb57140cf4ef5bab7606016e44333
Autor:
Valentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Ifigeneia Tzannou, Yovana Velazquez, Matthew French-Kim, Wingchi Leung, Suhasini Lulla, Catherine Robertson, Claudette Foreman, Tao Wang, Shaun Bulsara, Natalia Lapteva, Bambi Grilley, Matthew Ellis, Charles Kent Osborne, Angela Coscio, Julie Nangia, Helen E. Heslop, Cliona M. Rooney, Juan F. Vera, Premal Lulla, Mothaffar Rimawi, Ann M. Leen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Purpose: Adoptively transferred, ex vivo expanded multi-antigen-targeted T cells (multiTAA-T) represent a new, potentially effective, and nontoxic therapeutic approach for patients with breast cancer (BC). In this first-in-human trial, we investigate
Externí odkaz:
https://doaj.org/article/d2a1cea135ca47b2969fd4c6813e68ff
Autor:
Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Aster G. Workineh, Matthew French-Kim, Alejandro Torres Chavez, Sarah Gilmore, Cliona M. Rooney, Ann M. Leen
Publikováno v:
Haematologica.
Not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd614151faa6f2550a70f72fec376057
https://pubmed.ncbi.nlm.nih.gov/36373251
https://pubmed.ncbi.nlm.nih.gov/36373251
Autor:
Manik Kuvalekar, Adrian P. Gee, Juan F. Vera, Meng-Fen Wu, Rammurti T. Kamble, Tao Wang, Mrinalini Bilgi, Carlos A. Ramos, Ayumi Watanabe, Premal Lulla, Mira Jeong, Shamika Ketkar, Matthew French-Kim, Spyridoula Vasileiou, Betty Chung, George Carrum, Bambi Grilley, Ann M. Leen, Malcolm K. Brenner, Shivani Mukhi, Linghua Wang, Helen E. Heslop, Yumei Li, Ifigeneia Tzannou
Publikováno v:
Science Translational Medicine. 12
Multiple myeloma (MM) is an almost always incurable malignancy of plasma cells. Despite the advent of new therapies, most patients eventually relapse or become treatment-refractory. Consequently, therapies with nonoverlapping mechanisms of action tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::719f172636d0b9cd262e4edf695fdda6
https://doi.org/10.1126/scitranslmed.aaz3339
https://doi.org/10.1126/scitranslmed.aaz3339
Autor:
Carlos, Martes-Martinez, Cristian, Méndez-Sepúlveda, Joel, Millán-Molina, Matthew, French-Kim, Heriberto, Marín-Centeno, Giselle C, Rivera-Miranda, José J, Hernández-Muñoz, Jorge, Duconge-Soler
Publikováno v:
Puerto Rico health sciences journal. 36(3)
To evaluate the cost-utility of the pharmacogenetic-guided dosing of warfarin (PGx), when compared to the current dosing strategy.A Markov model was developed to assess the impact of the genotypingguided warfarin dosing in a hypothetical cohort of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f4932428b397ff88744c69e1bfbfb54
https://pubmed.ncbi.nlm.nih.gov/28915306
https://pubmed.ncbi.nlm.nih.gov/28915306